Our initial proposal focused exclusively on external whole-body photon irradiation. One ofthe main themes of this renewal is to assess the significance of the variety of other radiation scenarios which are likely to occur, in particular the effects of partial-body exposure, internal emitters, dose rate, and neutron exposure. This (new) irradiation core will provide the following new irradiation facilities: 1) Highly protracted low dose rate irradiations for cells and mice 2) Internal emitter mouse exposure 3) Partial body mouse irradiations 4) Neutron beams, simulating realistic scenarios. The Core will perfonn almost all the proposed mouse / blood irradiations, and sample acquisition, facilitating sample sharing between the Projects. The majority ofthe mouse irradiations will be done at Columbia University, either at the Center for Radiological Research Precision X-Ray X-Rad 320 irradiator (high dose rate / low dose rate whole body, lead-shielded partial body), or at the Columbia University Department of Radiation Oncology (conformal mouse organ irradiator), or at the Radiological Research Accelerator Facility (neutrons, and mixed neutrons + x rays). The internal emitter mouse irradiations will be performed at the Lovelace Respiratory Research Institute (LRRI) in Albuquerque. As all irradiated samples will be shared equally amongst the three projects, we expect the irradiation core to use approximately 30% of its resources to support Project 1, 30% to support Project 2, 30% to support Project 3, and 10% to support Pilot Projects.
A large scale radiological event could result in mass casualties from multiple types of radiation exposures, and there is thus a need for rapid, high-throughput biodosimetry to identify those who most require treatment. The Irradiation Core will provide facilities to support the extension of high-throughput approaches to be useful for partial body, low dose rate, internal emitter, and neutron exposures, and also for potentially identifying individuals with particular sensitivities to radiation.
|Sprung, Carl N; Ivashkevich, Alesia; Forrester, Helen B et al. (2015) Oxidative DNA damage caused by inflammation may link to stress-induced non-targeted effects. Cancer Lett 356:72-81|
|Shuryak, Igor; Lubin, Jay H; Brenner, David J (2014) Potential for adult-based epidemiological studies to characterize overall cancer risks associated with a lifetime of CT scans. Radiat Res 181:584-91|
|Turner, Helen C; Sharma, P; Perrier, J R et al. (2014) The RABiT: high-throughput technology for assessing global DSB repair. Radiat Environ Biophys 53:265-72|
|Repin, Mikhail; Turner, Helen C; Garty, Guy et al. (2014) Next generation platforms for high-throughput biodosimetry. Radiat Prot Dosimetry 159:105-10|
|Laiakis, Evagelia C; Mak, Tytus D; Anizan, Sebastien et al. (2014) Development of a metabolomic radiation signature in urine from patients undergoing total body irradiation. Radiat Res 181:350-61|
|Goudarzi, Maryam; Weber, Waylon; Mak, Tytus D et al. (2014) Development of urinary biomarkers for internal exposure by cesium-137 using a metabolomics approach in mice. Radiat Res 181:54-64|
|Forrester, Helen B; Li, Jason; Leong, Trevor et al. (2014) Identification of a radiation sensitivity gene expression profile in primary fibroblasts derived from patients who developed radiotherapy-induced fibrosis. Radiother Oncol 111:186-93|
|Forrester, Helen B; Sprung, Carl N (2014) Intragenic controls utilizing radiation-induced alternative transcript regions improves gene expression biodosimetry. Radiat Res 181:314-23|
|Luo, Xiuquan; Suzuki, Masatoshi; Ghandhi, Shanaz A et al. (2014) ATM regulates insulin-like growth factor 1-secretory clusterin (IGF-1-sCLU) expression that protects cells against senescence. PLoS One 9:e99983|
|Paul, Sunirmal; Ghandhi, Shanaz A; Weber, Waylon et al. (2014) Gene expression response of mice after a single dose of 137CS as an internal emitter. Radiat Res 182:380-9|
Showing the most recent 10 out of 85 publications